Genetic Determinants of Severe Hypertriglyceridemia: Rare Variants in LPL, APOC2, APOA5, GPIHBP1, LMF1, APOE and Polygenic Risk
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27125443 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Anastasia V Blokhina und 16 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3…. Hauptthemen laut MEDLINE: Hypertriglyceridemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Severe hypertriglyceridemia (HTG) is genetically heterogeneous, but its genetic architecture remains incompletely characterized. We investigated the genetic determinants of severe HTG in 123 patients with triglyceride (TG) levels > 5.0 mmol/L and available NGS data. We analyzed rare variants in LPL, APOC2, APOA5, GPIHBP1, LMF1, and APOE; the ε2/ε2 APOE genotype; and TG-polygenic risk score (PRS) based on 40 variants. Major genetic determinants were identified in 65.0% of individuals, including rare variants in chylomicronemia genes (24.4%; 28 variants, including 10 novel, 53.6% in LPL), rare APOE variants or the ε2/ε2 genotype (18.7%, overlapping with chylomicronemia variants in 4.1%), and an extreme polygenic burden (35.8%; PRS > 90th percentile), including 26.0% with isolated polygenic HTG. The remaining 35.0% had moderate-to-low PRS. The cohort was categorized into familial chylomicronemia syndrome (FCS, n = 7), multifactorial chylomicronemia syndrome (MCS, n = 21), polygenic HTG (n = 32), familial dysbetalipoproteinemia (FD, n = 20), and moderate-to-low PRS (n = 43) groups based on genetic determinants. FCS had the lowest PRS percentile (median 26) and the most distinct clinical profile, with the highest TG levels (median 30.60 mmol/L) and 6–24-fold higher odds of pancreatitis compared with other groups (p < 0.05), alongside a lower body mass index (median 23.0 kg/m2) than all groups except MCS, whereas FD had the lowest TG levels (10.20 mmol/L, p < 0.05). These results further advance the understanding of the complex genetic architecture of severe HTG and demonstrate that broader genetic analysis, including APOE and TG-PRS, may increase the yield of genetic determinants in severe HTG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.
- Department of General and Medical Genetics, Pirogov Russian National Research Medical University, 1, Ostrovityanova Str., 117997 Moscow, Russia.
- Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 1-73, Leninskie Gory, 119991 Moscow, Russia.
- Department of Natural Sciences, Novosibirsk State University, 1, Pirogova Str., 630090 Novosibirsk, Russia.
- Institute for Artificial Intelligence, Lomonosov Moscow State University, 1-73, Leninskie Gory, 119991 Moscow, Russia.
ORCID-Profile: Anastasia V Blokhina, Alexey N Meshkov, Marija Zaicenoka, Viktoria I Mikhailina, Stepan A Smetnev, Anna A Bukaeva, Alena S Limonova, Anna V Kiseleva, Anastasia A Zharikova, Elizaveta A Novokhatskaya, Elizaveta V Baranovskaya, Vasily E Ramensky, Oxana M Drapkina
Zitieren
APA
Blokhina, A. V., Meshkov, A. N., Ershova, A. I., Zaicenoka, M., Mikhailina, V. I., Smetnev, S. A., Bukaeva, A. A., Limonova, A. S., Kiseleva, A. V., Sotnikova, E. A., Zharikova, A. A., Novokhatskaya, E. A., Baranovskaya, E. V., Vyatkin, Y. V., Ramensky, V. E., Pokrovskaya, M. S., & Drapkina, O. M. (2026). Genetic Determinants of Severe Hypertriglyceridemia: Rare Variants in LPL, APOC2, APOA5, GPIHBP1, LMF1, APOE and Polygenic Risk. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27125443
Vancouver
Blokhina AV, Meshkov AN, Ershova AI, Zaicenoka M, Mikhailina VI, Smetnev SA, et al. Genetic Determinants of Severe Hypertriglyceridemia: Rare Variants in LPL, APOC2, APOA5, GPIHBP1, LMF1, APOE and Polygenic Risk. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27125443
BibTeX
@article{Blokhina2026,
author = {Blokhina, Anastasia V and Meshkov, Alexey N and Ershova, Alexandra I and Zaicenoka, Marija and Mikhailina, Viktoria I and Smetnev, Stepan A and Bukaeva, Anna A and Limonova, Alena S and Kiseleva, Anna V and Sotnikova, Evgeniia A and Zharikova, Anastasia A and Novokhatskaya, Elizaveta A and Baranovskaya, Elizaveta V and Vyatkin, Yuri V and Ramensky, Vasily E and Pokrovskaya, Maria S and Drapkina, Oxana M},
title = {Genetic Determinants of Severe Hypertriglyceridemia: Rare Variants in LPL, APOC2, APOA5, GPIHBP1, LMF1, APOE and Polygenic Risk},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27125443}
}
EUVIMED